Rapid Micro Biosystems, Inc. (NASDAQ:RPID – Get Free Report) was the target of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,180,000 shares, an increase of 190.3% from the February 28th total of 406,500 shares. Based on an average daily trading volume, of 501,000 shares, the days-to-cover ratio is currently 2.4 days. Approximately 5.8% of the shares of the stock are short sold.
Wall Street Analyst Weigh In
Separately, KeyCorp started coverage on shares of Rapid Micro Biosystems in a research note on Wednesday, February 12th. They issued an “overweight” rating and a $8.00 price target on the stock.
Read Our Latest Report on RPID
Rapid Micro Biosystems Stock Performance
Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) last released its earnings results on Friday, February 28th. The company reported ($0.22) earnings per share for the quarter, meeting the consensus estimate of ($0.22). Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. The business had revenue of $8.22 million for the quarter, compared to the consensus estimate of $8.20 million. Research analysts anticipate that Rapid Micro Biosystems will post -1.1 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Rapid Micro Biosystems
Hedge funds have recently modified their holdings of the business. Renaissance Technologies LLC boosted its position in Rapid Micro Biosystems by 122.9% during the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company’s stock worth $165,000 after acquiring an additional 100,942 shares during the last quarter. Citadel Advisors LLC acquired a new position in shares of Rapid Micro Biosystems during the 4th quarter worth approximately $65,000. Finally, Millennium Management LLC grew its position in shares of Rapid Micro Biosystems by 17.6% in the fourth quarter. Millennium Management LLC now owns 61,375 shares of the company’s stock valued at $55,000 after purchasing an additional 9,191 shares in the last quarter. 52.60% of the stock is currently owned by institutional investors and hedge funds.
About Rapid Micro Biosystems
Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Read More
- Five stocks we like better than Rapid Micro Biosystems
- 3 Dividend Kings To Consider
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Invest in Small Cap Stocks
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.